Search research articles
Contact Us
Filters
Showing results (11-20 of 14) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 14 results.
The Journal of Clinical Endocrinology and Metabolism
|
January 23, 2009
Assessment of the incremental value of recombinant thyrotropin stimulation before 2-[18F]-Fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography imaging to localize residual differentiated thyroid cancer
S Leboulleux, P R Schroeder, N L Busaidy, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 6, 2012
Efficacy and safety of three different cumulative doses of intravenous methylprednisolone for moderate to severe and active Graves' orbitopathy
L Bartalena, G E Krassas, W Wiersinga, et al.
Journal of Endocrinological Investigation
|
February 9, 2017
Does early response to intravenous glucocorticoids predict the final outcome in patients with moderate-to-severe and active Graves' orbitopathy?
L Bartalena, G Veronesi, G E Krassas, et al.
Annales D'Endocrinologie
|
January 13, 2009
Guidelines for the management of differentiated thyroid carcinomas of vesicular origin
F Borson-Chazot, S Bardet, C Bournaud, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 14) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 14 results.
The Journal of Clinical Endocrinology and Metabolism
|
January 23, 2009
Assessment of the incremental value of recombinant thyrotropin stimulation before 2-[18F]-Fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography imaging to localize residual differentiated thyroid cancer
S Leboulleux, P R Schroeder, N L Busaidy, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 6, 2012
Efficacy and safety of three different cumulative doses of intravenous methylprednisolone for moderate to severe and active Graves' orbitopathy
L Bartalena, G E Krassas, W Wiersinga, et al.
Journal of Endocrinological Investigation
|
February 9, 2017
Does early response to intravenous glucocorticoids predict the final outcome in patients with moderate-to-severe and active Graves' orbitopathy?
L Bartalena, G Veronesi, G E Krassas, et al.
Annales D'Endocrinologie
|
January 13, 2009
Guidelines for the management of differentiated thyroid carcinomas of vesicular origin
F Borson-Chazot, S Bardet, C Bournaud, et al.
Page
of 2